Absci Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ABSI Nasdaq 2830 www.absci.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Absci Corporation

Invivyd, Inc. (IVVD) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 7:15 am
Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Oct 29th, 2025 2:05 pm
Absci to Participate in Upcoming Investor Conferences - Oct 27th, 2025 6:00 am
Can Absci’s (ABSI) Accelerated Hair Loss Trial Timeline Reveal An Edge in Biotech Innovation? - Oct 18th, 2025 12:11 am
Absci (ABSI) Valuation in Focus as Early ABS-201 Hair Loss Trial Draws Investor Attention - Oct 15th, 2025 11:06 pm
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial - Oct 15th, 2025 6:00 am
Insider Spends US$255k Buying More Shares In Absci - Sep 27th, 2025 6:16 am
Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 - Sep 21st, 2025 7:26 am
Absci Corporation Taps Advanced Micro Devices Inc. (AMD) Chip for AI Drug Discovery Platform - Sep 16th, 2025 11:34 am
Absci (ABSI) Valuation in Focus Following Partnership With Oracle Cloud and AMD for AI Drug Discovery - Sep 15th, 2025 5:27 am
Sector Update: Health Care Stocks Climb Late Afternoon - Sep 11th, 2025 1:49 pm
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD - Sep 11th, 2025 6:00 am
Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg - Aug 25th, 2025 2:05 pm
Absci Second Quarter 2025 Earnings: Misses Expectations - Aug 14th, 2025 5:39 am
Absci Corp (ABSI) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges - Aug 13th, 2025 1:12 am
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates - Aug 12th, 2025 3:20 pm
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results - Aug 12th, 2025 2:05 pm
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Aug 7th, 2025 8:00 am
Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target - Aug 7th, 2025 12:00 am
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? - Aug 6th, 2025 8:00 am